1. Home
  2. MFC vs TAK Comparison

MFC vs TAK Comparison

Compare MFC & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manulife Financial Corporation

MFC

Manulife Financial Corporation

N/A

Current Price

$41.04

Market Cap

67.5B

Sector

Finance

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

N/A

Current Price

$21.82

Market Cap

69.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MFC
TAK
Founded
1887
1781
Country
Canada
Japan
Employees
37000
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.5B
69.1B
IPO Year
2002
2007

Fundamental Metrics

Financial Performance
Metric
MFC
TAK
Price
$41.04
$21.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $24.48
AVG Volume (30 Days)
1.8M
★ 3.1M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
★ 3.31%
1.12%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$91.93
$4.79
Revenue Next Year
N/A
$2.44
P/E Ratio
★ $16.52
$41.25
Revenue Growth
N/A
N/A
52 Week Low
$32.66
$14.16
52 Week High
$46.19
$21.86

Technical Indicators

Market Signals
Indicator
MFC
TAK
Relative Strength Index (RSI) 31.75 69.50
Support Level $39.48 $17.66
Resistance Level $41.43 N/A
Average True Range (ATR) 0.82 0.33
MACD -0.36 -0.01
Stochastic Oscillator 1.33 82.22

Price Performance

Historical Comparison
MFC
TAK

About MFC Manulife Financial Corporation

Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, asset management, and wealth management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 21% of 2025 adjusted earnings. The Asia segment operates across 12 countries and contributes around 38% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 16% of earnings. Manulife's global asset and wealth management business contributes approximately 25% of its earnings. The firm had around CAD 1.2 trillion in assets under management and administration as of the end of June 2026.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: